Pulmonary arterial hypertension in scleroderma: care gaps in screening by Janet E. Pope

Get full text

Precursors to Systemic Sclerosis and Systemic Lupus Erythematosus: From Undifferentiated Connective Tissue Disease to the Development of Identifiable Connective Tissue Diseases by Leonardo Martin Calderon, Janet E. Pope

Get full text

Systemic Lupus Erythematosus May Be a Risk Factor for Antimalarial‐Induced Retinopathy Compared With Other Rheumatologic Diseases by Hsin Yen Liu, Gemma Cramarossa, Janet E. Pope

Get full text

Systemic sclerosis: To subset or not to subset, that is the question by Sindhu R. Johnson, Frank van den Hoogen, Keshini Devakandan, Marco Matucci-Cerinic, Janet E. Pope

Get full text

Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open‐Label, Long‐Term Extension Studies up to 9.5 Years by Janet E. Pope, Edward Keystone, Shahin Jamal, Lisy Wang, Lara Fallon, John Woolcott, Irina Lazariciu, Douglass Chapman, Boulos Haraoui

Get full text

602 Childhood-onset Systemic Lupus Erythematosus: Long-term outcomes in a large multi-ethnic Ontario cohort by Janet E Pope, Johannes Roth, Earl D Silverman, Roberta A Berard, Deborah M Levy, Steve Jeoung, J Carter Thorne

Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids: A Post Hoc Analysis of Phase 3 Trials of Baricitinib by Janet E. Pope, Yvonne C. Lee, Jeffrey R. Curtis, Daojun Mo, Li Xie, Christina L. Dickson, Douglas E. Schlichting, Anabela Cardoso, Lee S. Simon, Peter C. Taylor

Get full text